CW January 2006

category image Volume 15
Issue Number 1
January 2006
ISSN 10593802

A Phase-I study Launched for a Plant-based Anticancer Drug

A new chemical compound derived semi-synthetically from a desert plant is being assessed for its anti-tumor activity in a Phase-I clinical trial in patients with relapsed or refractory cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

Source: News release
visit: www.clinicaltrials.gov

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW January 2006

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login